File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial

TitleEfficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial
Authors
Issue Date2020
PublisherAmerican Medical Association. The Journal's web site is located at http://oncology.jamanetwork.com/journal.aspx
Citation
JAMA Oncology, 2020, v. 6 n. 11, p. article no. e204564 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/289380
ISSN
2020 Impact Factor: 31.777
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.contributor.authorKang, YK-
dc.contributor.authorKim, TY-
dc.contributor.authorEl-Khoueiry, AB-
dc.contributor.authorSantoro, A-
dc.contributor.authorSangro, B-
dc.contributor.authorMelero, I-
dc.contributor.authorKudo, M-
dc.contributor.authorHou, MM-
dc.contributor.authorMatilla, A-
dc.contributor.authorTovoli, F-
dc.contributor.authorKnox, JJ-
dc.contributor.authorHe, AR-
dc.contributor.authorEl-Rayes, BF-
dc.contributor.authorAcosta-Rivera, M-
dc.contributor.authorLim, HY-
dc.contributor.authorNeely, J-
dc.contributor.authorShen, Y-
dc.contributor.authorWisniewski, T-
dc.contributor.authorAnderson, J-
dc.contributor.authorHsu, C-
dc.date.accessioned2020-10-22T08:11:49Z-
dc.date.available2020-10-22T08:11:49Z-
dc.date.issued2020-
dc.identifier.citationJAMA Oncology, 2020, v. 6 n. 11, p. article no. e204564-
dc.identifier.issn2374-2437-
dc.identifier.urihttp://hdl.handle.net/10722/289380-
dc.languageeng-
dc.publisherAmerican Medical Association. The Journal's web site is located at http://oncology.jamanetwork.com/journal.aspx-
dc.relation.ispartofJAMA Oncology-
dc.titleEfficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1001/jamaoncol.2020.4564-
dc.identifier.pmid33001135-
dc.identifier.pmcidPMC7530824-
dc.identifier.scopuseid_2-s2.0-85092634324-
dc.identifier.hkuros316115-
dc.identifier.volume6-
dc.identifier.issue11-
dc.identifier.spagearticle no. e204564-
dc.identifier.epagearticle no. e204564-
dc.identifier.isiWOS:000576434100007-
dc.publisher.placeUnited States-
dc.identifier.issnl2374-2437-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats